These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11769484)

  • 21. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
    Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
    Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continued benefit of lovastatin in the treatment of hypercholesterolemia in 36 patients.
    Wallace MB; Warren SG; Bates MC; Robinson PA
    W V Med J; 1995 Feb; 91(2):50-3. PubMed ID: 7610642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of the LDL-/HDL-cholesterol quotient on progression and regression of arteriosclerotic lesions. An analysis of controlled angiographic intervention studies].
    Gohlke H
    Wien Klin Wochenschr; 1992; 104(11):309-13. PubMed ID: 1621390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D
    N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract]   [Full Text] [Related]  

  • 26. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias.
    Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H
    Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 29. [An apheresis method in treatment of familial hypercholesterolemia].
    Derfler K
    Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150
    [No Abstract]   [Full Text] [Related]  

  • 30. [Familial hypercholesterolemia].
    Aguilar Salinas CA
    Rev Invest Clin; 2001; 53(3):254-65. PubMed ID: 11496713
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
    Rudling M
    Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening and follow-up of infants with dyslipoproteinemia.
    Roseneu M; Van Biervliet JP
    Prog Clin Biol Res; 1985; 188():79-86. PubMed ID: 3933016
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of the purified unsaponifiable fraction of soybean on primary type II hyperlipoproteinemia.
    Nakashima Y; Nakamura T; Aramaki Y; Kuroiwa A
    Artery; 1983; 12(3):199-211. PubMed ID: 6687319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Selection criteria for treatment of severe hyperlipoproteinemias with LDL apheresis].
    Bláha V; Zadák Z; Bláha M; Havel E; Solichová D; Brátová M; Malý J; Kmonícek L
    Cas Lek Cesk; 1998 Jul; 137(14):424-9. PubMed ID: 9748737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracorporeal LDL elimination with immunabsorption or heparin precipitation: a comparison in 10 patients.
    Richter WO; Vierneisel K; Schwandt P
    Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2484766
    [No Abstract]   [Full Text] [Related]  

  • 37. Extracorporeal plasma therapy: the HELP system for the treatment of hyper-beta-lipoproteinemia.
    Armstrong VW; Eisenhauer T; Noll D; Wieland H; Scheler F; Seidel D
    Prog Clin Biol Res; 1988; 255():327-35. PubMed ID: 3277203
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 39. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ENHANCE: food for the ostriches.
    Jackson G
    Int J Clin Pract; 2008 May; 62(5):667-8. PubMed ID: 18412925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.